.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
Deloitte
Colorcon
Mallinckrodt
Baxter
Citi
Novartis
Cipla
QuintilesIMS

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078657

« Back to Dashboard

NDA 078657 describes DESOXIMETASONE, which is a drug marketed by Actavis Mid Atlantic, Akorn, Fougera Pharms, Lupin Atlantis, Perrigo New York, Rising Pharms Inc, Altana, G And W Labs Inc, Glenmark Generics, Novel Labs Inc, Perrigo Israel, Teligent Pharma Inc, and Zydus Pharms Usa Inc, and is included in twenty-four NDAs. It is available from thirteen suppliers. Additional details are available on the DESOXIMETASONE profile page.

The generic ingredient in DESOXIMETASONE is desoximetasone. There are seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.

Summary for 078657

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)

Pharmacology for NDA: 078657

Medical Subject Heading (MeSH) Categories for 078657

Suppliers and Packaging for NDA: 078657

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 078657 ANDA E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. 0168-0151 0168-0151-60 1 TUBE in 1 CARTON (0168-0151-60) > 60 g in 1 TUBE
DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 078657 ANDA E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc. 0168-0151 0168-0151-15 1 TUBE in 1 CARTON (0168-0151-15) > 15 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.25%
Approval Date:Sep 28, 2012TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Baxter
Teva
Harvard Business School
Farmers Insurance
Accenture
Johnson and Johnson
Cerilliant
Fuji
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot